1. HBW Insight
  2. >>Health
  3. >>Rx-to-OTC Switch

Little Innovation In US OTC Switches For 20 Years, ACNU Won't Remove Impediments – Study

 
• By Malcolm Spicer

Of 45 switches since 2002, three added an indication to OTC market and three were “an exceptional innovation” offering “a genuinely novel OTC product, providing a new to OTC active pharmaceutical ingredient, pharmacological class, and indication,” Haleon researchers found.

• Source: Shutterstock

An analysis by Haleon plc researchers is critical of the US drug industry and the Food and Drug Administration’s record for Rx-to-OTC switches during the past 20 years, finding that “an overwhelming majority” didn’t add innovative products to the consumer health care marketplace.

The analysis published earlier in June in the journal Therapeutic Innovation & Regulatory Science, which authors Matt Fisher and Kapil...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rx-to-OTC Switch

EU Pharma Reform: Council Proposes Rx Exemption For Topical Antimicrobials

 
• By David Ridley

The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”

AESGP Annual Meeting: Commission Must ‘Think Carefully’ Before Reverse-Switching Antimicrobials

 
• By David Ridley

If the European Commission is serious about improving the competitiveness of the European Union, it should ditch the idea of making commonly used OTC antimicrobials like thrush treatments and cold sore creams prescription-only, warns Greek Medicines Agency president Evangelos Manolopoulos

Over The Counter: Driving Innovation In France’s Self-Care Market, With NèreS’ Luc Besançon

 
• By David Ridley

HBW Insight speaks to NèreS' executive director Luc Besançon about the key issues facing France's self-care industry, especially Rx-to-OTC switch and the revised Urban Wastewater Treatment Directive.

Allergy Ingredient Itch Warning, ACNU Final Rule Scratch Extent Of FDA Authority For Label Changes

 
• By Malcolm Spicer

Effective date for ACNU OTC switch final rule and finding of severe itching from long-term use of common allergy ingredients are bookends for limits of FDA’s authority for product label changes.

More from Health